San Raffaele
Radioembolization for liver cancer in Italy typically costs from $45,000 to $70,000. The total price depends on the dosimetry approach, disease stage, and hospital facility tier. In the US, similar procedures cost around $190,000 on average. Patients save around 70% compared to the US market. Standard inclusions often cover the radioisotope, interventional radiology fees, and essential hospital stay.
Bookimed Expert Insight: Choosing a research-focused institution provides access to breakthrough protocols not found elsewhere. San Raffaele in Milan is a prime example of this value. It is an IRCCS-accredited facility combining clinical care with intensive research. This status ensures patients receive treatment based on the latest oncological data. With over 52,000 operations annually, their high volume often translates to more refined procedural efficiency.
Why do patients choose Italy for radioembolization for liver cancer?
Access advanced Radioembolization for liver cancer solutions in trusted clinics .
| Italy | Turkey | Austria | |
| Radioembolization for liver cancer | from $45,000 | from $17,820 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Radioembolization for liver cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Radioembolization for liver cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Radioembolization for liver cancer journey.
Day 1: Arrival
Day 2: Pre-operation
Day 3: Radioembolization
Day 4: Post-operation
Week 1: Rehabilitation
Week 2 to 4: Rehabilitation
Please note that each patient"s journey to recovery may vary depending on their overall health, the size and location of the tumor, and their body"s response to the treatment.
The doctor is a hepatobiliary surgeon with over 25 years of experience and is a pioneer in minimally invasive liver surgery. They initiated and developed the San Raffaele laparoscopic liver resection program and currently serve as the Head of the Hepatobiliary and General Surgery Division at the San Raffaele Research Hospital in Milan. As the Scientific Director of the Italian Group of Minimally Invasive Liver Surgery, their clinical and research focus includes surgical oncology for colorectal liver metastases, cholangiocarcinoma, and hepatocellular carcinoma. The doctor has performed over 3,000 liver resections, with more than 900 laparoscopic procedures.